| Product Code: ETC6754947 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Targeted Cancer Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Targeted Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Targeted Cancer Therapy Market - Industry Life Cycle |
3.4 China Targeted Cancer Therapy Market - Porter's Five Forces |
3.5 China Targeted Cancer Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Targeted Cancer Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Targeted Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing adoption of targeted therapy due to its effectiveness |
4.2.3 Technological advancements in cancer treatment |
4.2.4 Supportive government initiatives and policies |
4.2.5 Rising healthcare expenditure and awareness about personalized medicine |
4.3 Market Restraints |
4.3.1 High cost associated with targeted cancer therapy |
4.3.2 Limited access to advanced cancer treatment facilities in rural areas |
4.3.3 Stringent regulatory processes for approval of targeted cancer therapies |
4.3.4 Potential side effects and resistance to targeted therapies |
4.3.5 Competition from alternative treatment options such as chemotherapy and surgery |
5 China Targeted Cancer Therapy Market Trends |
6 China Targeted Cancer Therapy Market, By Types |
6.1 China Targeted Cancer Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Targeted Cancer Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Targeted Cancer Therapy Market Revenues & Volume, By Tumor Antigens As Targets of Antibodies, 2021- 2031F |
6.1.4 China Targeted Cancer Therapy Market Revenues & Volume, By Development of Antibodies for Clinical Purposes, 2021- 2031F |
6.1.5 China Targeted Cancer Therapy Market Revenues & Volume, By Complement Dependent Cytotoxicity (CDC), 2021- 2031F |
6.1.6 China Targeted Cancer Therapy Market Revenues & Volume, By Signal Transduction Changes, 2021- 2031F |
6.2 China Targeted Cancer Therapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Targeted Cancer Therapy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 China Targeted Cancer Therapy Market Revenues & Volume, By Clinic, 2021- 2031F |
7 China Targeted Cancer Therapy Market Import-Export Trade Statistics |
7.1 China Targeted Cancer Therapy Market Export to Major Countries |
7.2 China Targeted Cancer Therapy Market Imports from Major Countries |
8 China Targeted Cancer Therapy Market Key Performance Indicators |
8.1 Patient survival rates post targeted therapy treatment |
8.2 Adoption rate of targeted therapies in different regions of China |
8.3 Research and development investment in innovative targeted cancer therapies |
8.4 Number of clinical trials and successful drug approvals for targeted therapy |
8.5 Patient satisfaction and quality of life improvements after targeted cancer treatment |
9 China Targeted Cancer Therapy Market - Opportunity Assessment |
9.1 China Targeted Cancer Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Targeted Cancer Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Targeted Cancer Therapy Market - Competitive Landscape |
10.1 China Targeted Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Targeted Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here